Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
CAR T Cell Therapy for Brain Cancer
Recruiting1 awardPhase 1
Houston, Texas
This trial is for patients with high grade glioma (HGG), diffuse intrinsic pontine glioma (DIPG), medulloblastoma, or another rare brain cancer. Patients will receive an infusion of GD2-C7R T cells, which are special immune cells that have been modified to better recognize and kill cancer cells. Researchers will also evaluate how long the GD2-C7R T cells can be detected in the blood and what effect they have on brain cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service